# OpenEvidence — Healthcare Investment Intelligence

> ai_healthcare · Series C+. MedFuel Intel profile as of 2026-06-12.

OpenEvidence raised $75M in Series A in February 2025 led by Sequoia Capital and $210M in July 2025 led by GV and Kleiner Perkins, valuing the company at $3.5B. It provides an AI-based clinical decision support platform used by over 40% of U.S. physicians, sourcing from 300+ medical journals.[2]

## Key facts (as of 2026-06-12)
- Sector: ai_healthcare
- Stage: Series C+
- Website: https://www.openevidence.com/

## MedFuel assessment
- Intelligence score: 0/100
- Analyses: 0
- Sentiment trend: stable

---
Source: MedFuel Intel — https://medfuelintel.com/company/openevidence. Figures reflect MedFuel's analysis; verify against primary sources (SEC, FDA, ClinicalTrials.gov) before any investment decision.